229 related articles for article (PubMed ID: 32020821)
1. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
Li M; He F; Zhang Z; Xiang Z; Hu D
J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
[TBL] [Abstract][Full Text] [Related]
2.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
3. Untangling the evolutionary roots of lung cancer.
Devarakonda S; Govindan R
Nat Commun; 2019 Jul; 10(1):2979. PubMed ID: 31278259
[TBL] [Abstract][Full Text] [Related]
4. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in
Walia HK; Verma U; Singh N; Sharma S
Br J Biomed Sci; 2019 Oct; 76(4):198-200. PubMed ID: 31218944
[No Abstract] [Full Text] [Related]
7. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Meng F; Zhang L; Ren Y; Ma Q
J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
[TBL] [Abstract][Full Text] [Related]
8. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
12. CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma.
Matsubara E; Komohara Y; Shinchi Y; Mito R; Fujiwara Y; Ikeda K; Shima T; Shimoda M; Kanai Y; Sakagami T; Suzuki M
Pathol Int; 2021 Oct; 71(10):666-673. PubMed ID: 34231937
[TBL] [Abstract][Full Text] [Related]
13. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.
Samad A; Jafar T; Rafi JH
Genomics; 2020 Nov; 112(6):4912-4923. PubMed ID: 32916258
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
15. Association of specific gene mutations derived from machine learning with survival in lung adenocarcinoma.
Cho HJ; Lee S; Ji YG; Lee DH
PLoS One; 2018; 13(11):e0207204. PubMed ID: 30419062
[TBL] [Abstract][Full Text] [Related]
16. High Expression of
Zhao T; Qian K; Zhang Y
J Comput Biol; 2020 Jun; 27(6):948-957. PubMed ID: 31553229
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.
Shi YX; Zhu T; Zou T; Zhuo W; Chen YX; Huang MS; Zheng W; Wang CJ; Li X; Mao XY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Dec; 7(51):85235-85243. PubMed ID: 27835911
[TBL] [Abstract][Full Text] [Related]
18. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
Elife; 2018 Nov; 7():. PubMed ID: 30475207
[TBL] [Abstract][Full Text] [Related]
19. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a Protein Prognostic Model for Lung Squamous Cell Carcinoma.
Fang X; Liu X; Weng C; Wu Y; Li B; Mao H; Guan M; Lu L; Liu G
Int J Med Sci; 2020; 17(17):2718-2727. PubMed ID: 33162799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]